Press "Enter" to skip to content

New patent for Horizon Therap drug RAVICTI

0
Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for RAVICTI
Annual Drug Patent Expirations for RAVICTI

Ravicti is a drug marketed by Horizon Therap Us and is included in one NDA. It is available from one supplier. There are fifteen patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for RAVICTI.

This drug has ninety-three patent family members in twenty-nine countries.

The generic ingredient in RAVICTI is glycerol phenylbutyrate. One supplier is listed for this compound. Additional details are available on the glycerol phenylbutyrate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions